Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9272411rdf:typepubmed:Citationlld:pubmed
pubmed-article:9272411lifeskim:mentionsumls-concept:C0206178lld:lifeskim
pubmed-article:9272411lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:9272411lifeskim:mentionsumls-concept:C0070895lld:lifeskim
pubmed-article:9272411lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:9272411lifeskim:mentionsumls-concept:C0238607lld:lifeskim
pubmed-article:9272411lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:9272411lifeskim:mentionsumls-concept:C0040808lld:lifeskim
pubmed-article:9272411pubmed:issue5lld:pubmed
pubmed-article:9272411pubmed:dateCreated1997-9-25lld:pubmed
pubmed-article:9272411pubmed:abstractTextTo compare the pharmacokinetics of foscarnet administered as an infusion twice daily (BID) or thrice daily (TID), and to compare the effects on the electrolyte balance, cardiac and renal functions over a 3-week induction treatment of Cytomegalovirus (CMV) retinitis.lld:pubmed
pubmed-article:9272411pubmed:languageenglld:pubmed
pubmed-article:9272411pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9272411pubmed:citationSubsetIMlld:pubmed
pubmed-article:9272411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9272411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9272411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9272411pubmed:statusMEDLINElld:pubmed
pubmed-article:9272411pubmed:issn0031-6970lld:pubmed
pubmed-article:9272411pubmed:authorpubmed-author:CarosiGGlld:pubmed
pubmed-article:9272411pubmed:authorpubmed-author:HedmanAAlld:pubmed
pubmed-article:9272411pubmed:authorpubmed-author:SuterFFlld:pubmed
pubmed-article:9272411pubmed:authorpubmed-author:CastelliFFlld:pubmed
pubmed-article:9272411pubmed:authorpubmed-author:ZeroliCClld:pubmed
pubmed-article:9272411pubmed:authorpubmed-author:TrespiGGlld:pubmed
pubmed-article:9272411pubmed:authorpubmed-author:TomasoniLLlld:pubmed
pubmed-article:9272411pubmed:issnTypePrintlld:pubmed
pubmed-article:9272411pubmed:volume52lld:pubmed
pubmed-article:9272411pubmed:ownerNLMlld:pubmed
pubmed-article:9272411pubmed:authorsCompleteYlld:pubmed
pubmed-article:9272411pubmed:pagination397-401lld:pubmed
pubmed-article:9272411pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:meshHeadingpubmed-meshheading:9272411-...lld:pubmed
pubmed-article:9272411pubmed:year1997lld:pubmed
pubmed-article:9272411pubmed:articleTitleComparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis.lld:pubmed
pubmed-article:9272411pubmed:affiliationClinic of Infectious and Tropical Diseases, University of Brescia, Italy.lld:pubmed
pubmed-article:9272411pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9272411pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9272411pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9272411pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:9272411pubmed:publicationTypeMulticenter Studylld:pubmed